Pluristem - Asset Resilience Ratio

Latest as of March 2022: 48.26%

Pluristem (PSTI) has an Asset Resilience Ratio of 48.26% as of March 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

ILA38.19 Million

≈ $102.38K USD Cash + Short-term Investments

Total Assets

ILA79.13 Million

≈ $212.14K USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2021)

This chart shows how Pluristem's Asset Resilience Ratio has changed over time. Check Pluristem (PSTI) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Pluristem's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PSTI market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	ILA0.00	0%
Short-term Investments	ILA38.19 Million	48.26%
Total Liquid Assets	ILA38.19 Million	48.26%

Asset Resilience Insights

Very High Liquidity: Pluristem maintains exceptional liquid asset reserves at 48.26% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Pluristem Industry Peers by Asset Resilience Ratio

Compare Pluristem's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hadasit Bio TA:HDST	Biotechnology & Medical Research	57.00%
Purple Biotech Ltd TA:KTOV	Biotechnology & Medical Research	0.01%
Peptron Inc KQ:087010	Biotechnology & Medical Research	57.41%
Bioneer Corporation KQ:064550	Biotechnology & Medical Research	14.92%
MEDIPOST Co. Ltd KQ:078160	Biotechnology & Medical Research	0.72%
Cell Biotech Co. Ltd KQ:049960	Biotechnology & Medical Research	54.84%
Macrogen Inc KQ:038290	Biotechnology & Medical Research	3.56%
Panagene Inc KQ:046210	Biotechnology & Medical Research	0.14%

Annual Asset Resilience Ratio for Pluristem (2014–2021)

The table below shows the annual Asset Resilience Ratio data for Pluristem.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2021-06-30	36.04%	ILA33.71 Million ≈ $90.37K	ILA93.54 Million ≈ $250.77K	-21.21pp
2020-06-30	57.25%	ILA37.51 Million ≈ $100.57K	ILA65.53 Million ≈ $175.69K	-5.35pp
2019-06-30	62.60%	ILA19.60 Million ≈ $52.54K	ILA31.31 Million ≈ $83.94K	+8.49pp
2018-06-30	54.10%	ILA21.08 Million ≈ $56.51K	ILA38.96 Million ≈ $104.45K	-2.91pp
2017-06-30	57.01%	ILA21.40 Million ≈ $57.37K	ILA37.53 Million ≈ $100.63K	+0.45pp
2016-06-30	56.56%	ILA25.98 Million ≈ $69.66K	ILA45.94 Million ≈ $123.17K	+13.40pp
2015-06-30	43.16%	ILA29.42 Million ≈ $78.87K	ILA68.16 Million ≈ $182.72K	-23.59pp
2014-06-30	66.75%	ILA49.41 Million ≈ $132.47K	ILA74.02 Million ≈ $198.45K	--

pp = percentage points

About Pluristem

TA:PSTI Israel Biotechnology & Medical Research

Market Cap

$44.19 Million

ILA16.48 Billion ILA

Market Cap Rank

#22301 Global

#310 in Israel

Share Price

ILA509.50

Change (1 day)

-2.02%

52-Week Range

ILA501.00 - ILA1831.00

All Time High

ILA72010.00